Xcout IntelEthyreal Bio
Ethyreal Bio is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing precision therapies for thyroid diseases with high unmet medical needs.
Subscribe to see Ethyreal Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ethyreal Bio at a glance
Ethyreal Bio is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $101M in June 2026. Xcout tracks 8 named people at Ethyreal Bio, including Niranjan Kameswaran (CEO).
Ethyreal Bio leadership
- Niranjan KameswaranCEO
- Niranjan Kameswaran, Ph.D.Chief Executive Officer
- Phillip Samayoa, Ph.D.Chief Operating Officer
- Jessica StrommeChief Development Officer
- Kelly Foster, Ph.D.Chief Scientific Officer
- Stephen Huang, M.D.SVP, Clinical Development
2 more named people on record for Ethyreal Bio, with roles, board committees and tenure — see the full roster →
Ethyreal Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $101M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Ethyreal Bio competitors
A few of Ethyreal Bio's closest competitors — see the full list of competitors and alternatives →
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Stipple Bio, Inc. is a private biotechnology company headquartered in Cambridge, Massachusetts, United States, focused on harnessing epitope-level precision in therapeutics.
Zag Bio is a biotechnology research company headquartered in Cambridge, Massachusetts. The enterprise focuses on developing innovative therapies for autoimmune diseases by targeting the thymus gland to engage the body's natural T cell central tolerance mechanisms.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Get Ethyreal Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ethyreal Bio in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access